Sharing of Injection Drug Preparation Equipment Is Associated With HIV Infection: A Cross-sectional Study

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2019 Apr 26

PMID 31021986

Citations 23

Authors

Laura J Ball

Klajdi Puka

Mark Speechley

Ryan Wong

Brian Hallam

Joshua C Wiener

Sharon Koivu

Michael S Silverman

Affiliations

Soon will be listed here.

Abstract

Background: Sharing needles/syringes and sexual transmission are widely appreciated as means of HIV transmission among persons who inject drugs (PWIDs). London, Canada, is experiencing an outbreak of HIV among PWIDs, despite a large needle/syringe distribution program and low rates of needle/syringe sharing.

Objective: To determine whether sharing of injection drug preparation equipment (IDPE) is associated with HIV infection.

Methods: Between August 2016 and June 2017, individuals with a history of injection drug use and residence in London were recruited to complete a comprehensive questionnaire and HIV testing.

Results: A total of 127 participants were recruited; 8 were excluded because of failure to complete HIV testing. The remaining 35 HIV-infected (cases) and 84 HIV-uninfected (controls) participants were assessed. Regression analysis found that sharing IDPE, without sharing needles/syringes, was strongly associated with HIV infection (adjusted odds ratio: 22.1, 95% confidence interval: 4.51 to 108.6, P < 0.001).

Conclusions: Sharing of IDPE is a risk factor for HIV infection among PWIDs, even in the absence of needle/syringe sharing. Harm reduction interventions to reduce HIV transmission associated with this practice are urgently needed.

Citing Articles

Rapid initiation of antiretrovirals at a syringe services program for people with HIV who inject drugs.

Plesons M, Yang W, Sansbury G, Suarez E, Collington C, Ekowo E Ann Med. 2025; 57(1):2461670.

PMID: 39928115 PMC: 11812110. DOI: 10.1080/07853890.2025.2461670.

HIV-Host Cell Interactions.

Masenga S, Mweene B, Luwaya E, Muchaili L, Chona M, Kirabo A Cells. 2023; 12(10.

PMID: 37408185 PMC: 10216808. DOI: 10.3390/cells12101351.

High levels of interest in access to free safer smoking equipment to reduce injection frequency among people who inject drugs in Seattle, Washington.

Reid M, Oliphant-Wells T, Moreno C, Ketchum J, Fitzpatrick T, McMahan V Drug Alcohol Depend Rep. 2023; 7:100163.

PMID: 37214756 PMC: 10193167. DOI: 10.1016/j.dadr.2023.100163.

The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines.

Madhuravasal Krishnan J, Kong L, Karns R, Medvedovic M, Sherman K, Blackard J Viruses. 2023; 15(4).

PMID: 37113007 PMC: 10145664. DOI: 10.3390/v15041027.

Network ethnic homophily and injection equipment sharing among Latinx and White non-Latinx people who inject drugs.

Lee E, Pineros J, Williams L, Mackesy-Amiti M, Molina Y, Boodram B J Ethn Subst Abuse. 2023; 23(4):1080-1099.

PMID: 36853193 PMC: 10460831. DOI: 10.1080/15332640.2023.2181259.

References

Hagan H, Thiede H, Weiss N, Hopkins S, Duchin J, ALEXANDER E . Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001; 91(1):42-6. PMC: 1446500. DOI: 10.2105/ajph.91.1.42. View

Des Jarlais D, Kerr T, Carrieri P, Feelemyer J, Arasteh K . HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. AIDS. 2016; 30(6):815-26. PMC: 4785082. DOI: 10.1097/QAD.0000000000001039. View

Roy E, Arruda N, Bourgois P . The growing popularity of prescription opioid injection in downtown Montréal: new challenges for harm reduction. Subst Use Misuse. 2011; 46(9):1142-50. PMC: 3161198. DOI: 10.3109/10826084.2011.552932. View

Des Jarlais D, Friedman S . HIV infection among persons who inject illicit drugs: problems and prospects. J Acquir Immune Defic Syndr (1988). 1988; 1(3):267-73. View

McCoy C, Metsch L, Chitwood D, Shapshak P, Comerford S . Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S25-9. DOI: 10.1097/00042560-199802001-00006. View

Broz D, Wejnert C, Pham H, DiNenno E, Heffelfinger J, Cribbin M . HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. MMWR Surveill Summ. 2014; 63(6):1-51. View

Abadie R, Welch-Lazoritz M, Gelpi-Acosta C, Reyes J, Dombrowski K . Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico. Harm Reduct J. 2016; 13:10. PMC: 4784433. DOI: 10.1186/s12954-016-0099-9. View

Roy E, Arruda N, Leclerc P, Haley N, Bruneau J, Boivin J . Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users. Drug Alcohol Depend. 2012; 126(1-2):246-50. DOI: 10.1016/j.drugalcdep.2012.05.018. View

Jones C, Christensen A, Gladden R . Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004-2013. Drug Alcohol Depend. 2017; 176:89-95. PMC: 9244861. DOI: 10.1016/j.drugalcdep.2017.03.011. View

10.

Zibbell J, Hart-Malloy R, Barry J, Fan L, Flanigan C . Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health. 2014; 104(11):2226-32. PMC: 4202941. DOI: 10.2105/AJPH.2014.302142. View

11.

Clatts M, Heimer R, Abdala N, Goldsamt L, Sotheran J, Anderson K . HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. J Acquir Immune Defic Syndr. 2000; 22(2):194-9. DOI: 10.1097/00126334-199910010-00013. View

12.

Aspinall E, Nambiar D, Goldberg D, Hickman M, Weir A, Van Velzen E . Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2013; 43(1):235-48. DOI: 10.1093/ije/dyt243. View

13.

Page J, Shapshak P, Duran E, Even G, Moleon-Borodowski I, Llanusa-Cestero R . Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness. AIDS Patient Care STDS. 2006; 20(8):576-85. DOI: 10.1089/apc.2006.20.576. View

14.

Wood E, Kerr T, Marshall B, Li K, Zhang R, Hogg R . Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009; 338:b1649. PMC: 2675696. DOI: 10.1136/bmj.b1649. View

15.

Strathdee S, Sherman S . The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2004; 80(4 Suppl 3):iii7-14. PMC: 3456264. DOI: 10.1093/jurban/jtg078. View

16.

Abdul-Quader A, Feelemyer J, Modi S, Stein E, Briceno A, Semaan S . Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013; 17(9):2878-92. PMC: 6509353. DOI: 10.1007/s10461-013-0593-y. View

17.

Mathers B, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee S . Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008; 372(9651):1733-45. DOI: 10.1016/S0140-6736(08)61311-2. View

18.

Koester S, Glanz J, Baron A . Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005; 9(1):27-39. DOI: 10.1007/s10461-005-1679-y. View

19.

MacArthur G, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J . Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012; 345:e5945. PMC: 3489107. DOI: 10.1136/bmj.e5945. View

20.

Corson S, Greenhalgh D, Taylor A, Palmateer N, Goldberg D, Hutchinson S . Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing. Drug Alcohol Depend. 2013; 133(1):172-9. DOI: 10.1016/j.drugalcdep.2013.05.014. View